Wolverine Asset Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Wolverine Asset Management’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-39,899	Closed	-$4.62M	–	2181
2023 Q3	$4.62M	Buy	39,899 +7,314	+22%	+$786K	0.05%	332
2023 Q2	$3.35M	Sell	32,585 -1,830	-5%	-$193K	0.04%	387
2023 Q1	$3.76M	Buy	34,415 +14,982	+77%	+$1.66M	0.04%	386
2022 Q4	$2.21M	Buy	+19,433	New	+$1.61M	0.02%	539
2021 Q2	–	Sell	-1,443	Closed	-$132K	–	2655
2021 Q1	$132K	Sell	1,443 -13,777	-91%	-$1.16M	﹤0.01%	1370
2020 Q4	$1.11M	Buy	15,220 +7,843	+106%	+$583K	0.01%	619
2020 Q3	$573K	Buy	+7,377	New	+$508K	0.01%	706
2020 Q2	–	Sell	-1,058	Closed	-$31K	–	1938
2020 Q1	$31K	Sell	1,058 -1,442	-58%	-$48.8K	﹤0.01%	1234
2019 Q4	$90K	Hold	2,500	–	–	﹤0.01%	1130
2019 Q3	$68K	Buy	2,500 +1,500	+150%	+$38.8K	﹤0.01%	1177
2019 Q2	$24K	Hold	1,000	–	–	﹤0.01%	1259
2019 Q1	$26K	Buy	+1,000	New	+$23.7K	﹤0.01%	1227
2017 Q3	–	Sell	-3,000	Closed	-$35K	–	1566
2017 Q2	$35K	Hold	3,000	–	–	﹤0.01%	1151
2017 Q1	$44K	Buy	3,000 +1,600	+114%	+$25.9K	﹤0.01%	1030
2016 Q4	$22K	Buy	+1,400	New	+$25.4K	﹤0.01%	1080

Other funds holding HZNP

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

VWA

Valued Wealth Advisors Holladay, Utah $247M AUM 21.93% 1-Year Est. Return

FSWA

Financial Synergies Wealth Advisors Houston, Texas $1.05B AUM 19.75% 1-Year Est. Return

BCMLT

Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Wolverine Asset Management's HZNP Position: Q4 2023 in Review

Wolverine Asset Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 39,899 shares — an estimated $4.62M sold.

Wolverine Asset Management first reported a position in HZNP in Q4 2016 and held it in 15 quarters. The position peaked at $4.62M in Q3 2023. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

Wolverine Asset Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
Wolverine Asset Management sold 39,899 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $4.62M.
Wolverine Asset Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2016 and held it in 15 quarters.
Wolverine Asset Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $4.62M in Q3 2023.
6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Wolverine Asset Management's 13F filing for Q4 2023, filed 1 Feb 2024.